Insights from Digital Pharma Leaders
Refine Search
Biotechnology
This week, we discuss a novel AI-driven approach to drug development, and its potential to transform the treatment of cancer and autoimmune diseases. 14 November 2024
Pharmaceutical
Digital therapeutics company GAIA has announced the signing of a licensing agreement for attexis with fellow German firm MEDICE Arzneimittel Pütter. 14 November 2024
Biotechnology
Privately-held Boston-based biopharma FogPharma has announced a name change and unveiled a new AI-based platform. 11 November 2024
Pharmaceutical
A review has found that complexities and inefficiencies within the UK’s health data infrastructure are hindering the effective use of these resources that are critical for improving people’s health. 8 November 2024
Pharmaceutical
An Expert View from Nick Petschek, Managing Director EMEA, Kotter International. 18 October 2024
Pharmaceutical
California-based AI company Suki has raised $70 million in new funding to accelerate the growth of its AI-powered voice solutions in healthcare. 11 October 2024
Pharmaceutical
Machine learning-enabled drug discovery and development company insitro has announced the execution of three strategic agreements with Eli Lilly. 10 October 2024
Biotechnology
China’s Quantum Pharmaceuticals has announced a significant licensing agreement between its biologics-focused subsidiary, Ailux Biologics, and Johnson & Johnson. 10 October 2024
Pharmaceutical
The UK has launched a new Regulatory Innovation Office (RIO), with the goal of accelerating new technologies, particularly in sectors like biotech and healthcare, by reducing regulatory barriers. 9 October 2024
Biotechnology
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Biotechnology
Californian companies Gilead Sciences and Genesis Therapeutics have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets. 10 September 2024
Biotechnology
ZipBio, a newly launched start-up based in Seattle, USA, is aiming to set a new standard in the development of biologics and gene therapies by utilizing generative AI technology. 9 September 2024
Pharmaceutical
An Expert View from Vikas Krishan, chief digital business officer at Altimetrik. 4 September 2024
Pharmaceutical
Otsuka Pharmaceuticals says that its subsidiaries Otsuka Precision Health, Inc. (OPH) and Click Therapeutics (Click) have launched Rejoyn (developed as CT-152). 19 August 2024
Pharmaceutical
CytoReason’s $80 million venture round may not have been the biggest in July, but it is one of a growing number of investor bets on AI powered drug discovery this year. 7 August 2024
Pharmaceutical
California’s ReviR Therapeutics has completed a $30 million series A financing round, bringing its total funding to $54 million. 29 July 2024
Pharmaceutical
An Expert View from Brendan Frey, founder and chief innovation officer of Deep Genomics. 4 July 2024
Biotechnology
AI-focused start-up Formation Bio has raised $372 million in a series D financing. 27 June 2024
Pharmaceutical
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) across the entire pharmacovigilance (PV) value chain. However, over the next two years, the industry expects this number to only marginally shift to just 51%. 17 June 2024
Biotechnology
London-listed biotech firm PureTech Health’s founded entity, Akili Interactive, has gained US Food and Drug Administration clearance for EndeavorRx (AKL-T01) as a prescription treatment for children with attention-deficit/hyperactivity disorder (ADHD). 16 June 2020
Pharmaceutical
The COVID-19 pandemic did not stop China from launching its national blockchain-based service network (BSN) last month. 5 May 2020
Pharmaceutical
The Artificial Intelligence (AI) and Machine Learning industry is growing at an extraordinary rate, with healthcare professionals increasingly turning to AI to transform the patient experience and quality of care. 23 April 2020
Pharmaceutical
Digital marketing in pharma is gaining increasing importance in recent times and Indian drugmaker can be termed as a pioneer in this space from the Indian market perspective, as it has successfully used a digital strategy to promote disease awareness and grow leadership position in asthma, says data and analytics company GlobalData. 4 March 2020
Pharmaceutical
An interview with Rob DiCicco, deputy chief health officer, IBM Watson Health. 4 March 2020
Pharmaceutical
Researchers at the Massachusetts Institute of Technology (MIT) have claimed that they have identified a powerful new antibiotic compound using artificial intelligence (AI). 21 February 2020
Pharmaceutical
Spain's leading drugmaker Almirall is to work with Plug and Play, a health tech firm, to accelerate digital innovation in dermatology. 6 February 2020
Pharmaceutical
finnCap, an adviser and broker to ambitious growth companies, has released a new report showing the extent to which healthcare companies can benefit from employing artificial intelligence (AI). 31 January 2020
Biotechnology
UK-based Exscientia has offered some compelling evidence to prove its claim to be the leading AI-driven drug discovery company. 30 January 2020
Pharmaceutical
A new report has been published by the joint Big Data Task Force of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). 20 January 2020
Pharmaceutical
Novadiscovery, a French pioneer in the use of in silico clinical trials to predict drug efficacy and optimize clinical development, has raised five million euros ($6 million) in a Series A financing. 9 January 2020
Pharmaceutical
Global nonprofit The Pistoia Alliance has issued a new report into the future of the life science and healthcare industries. 11 December 2019
Pharmaceutical
In recent years, digital transformation has gone from being a promise to a reality, writes Francesca Domenech Wuttke, Chief Digital Officer, Almirall. 2 December 2019
Pharmaceutical
Given that they have a certain luxury for blue sky thinking and the capacity to lead rather than react to industry and societal trends, for big pharma companies to have highly ambitious digital strategies is not unusual. 28 November 2019
Pharmaceutical
Swedish drug developer Orexo today announced it has acquired the exclusive US rights to vorvida, a digital therapy for the treatment of alcohol use disorder (AUD), from GAIA AG, a global leader in digital therapeutics. 27 November 2019
Pharmaceutical
Anglo-Swedish pharma major AstraZeneca’s love affair with China shows no sign of cooling off, with the company now announcing three new projects in the Asian country to advance its R&D efforts. 6 November 2019
Pharmaceutical
Google and other search engines are putting consumers at risk of buying fake pharmaceutical products by refusing to remove these websites in their search results. 22 October 2019
Pharmaceutical
China is currently the second largest pharmaceutical market in the world and is aiming to be a major innovator as well, as part of its ‘Made in China 2025’ program. 14 October 2019
Pharmaceutical
Germany’s Bayer has opened LifeHub UK, the latest in a series of innovation hubs focused on artificial intelligence. 10 October 2019
Biotechnology
Hong Kong-based Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program AI drug discovery collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceutical (CTFH), taking on previously undruggable targets. 9 October 2019
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze